PURE ONE Omega-3 Formulated with Non-Hexane Extracted Algae Oil DHA

Chapel Hill, NC, April 25, 2012 --(PR.com)-- Source-Omega today announced their PURE ONE Omega-3 supplement is now made using only non-hexane extracted ingredients including the algae oil and the sunflower lecithin. PURE ONE's flagship debut features their finished premium bulk formulation of SOURCE OIL™, the only water extracted non-hexane non-solvent processed algae DHA.

PURE ONE bulk softgels are available for private labeling. PURE ONE is re-launching in July as an Active PharmaceuticaI Ingredient (API) standardized to deliver at least 300 mg DHA per softgel for targeting clinical nutrition markets worldwide. The product is intended for heart and brain health maintenance and is safe for type 2 diabetics.

In 2007 company founder Scott Doughman, PhD, Source-Omega’s CEO and Chief Scientific Officer, published a representative fatty acid profile from hexane extracted algae oil (Curr Diabetes Rev. 2007, 3:198-203). For comparison, the company's 2012 SOURCE OIL Certificate of Analysis is available on the Source-Omega website for open review (www.source-omega.com).

"Hexane extraction of algae apparently produces a cleaner lipid profile than non-hexane extracted oil," Doughman said. “Our comparative data is interpreted to suggest hexane extracts all types of lipids indiscriminately, not just the DHA triglycerides. Although the oils are from the same strain, water extracted oil is almost entirely composed of DHA triglycerides. By eliminating the hexane extraction, this helps improve oil DHA concentrations from 35 percent to 40 percent. Reformulation with SOURCE OIL offers both value and quality advantages to private contractors.”

PURE ONE was first-to-market on Earth Day 2008 with algae oil in algae-based softgels. The brand is now positioned for private clinical distribution, no longer competing for over the counter self-space. As a flagship brand, PURE ONE helps communicate the use of algae oil through Source-Omega’s own peer reviewed publications. Their reviews were the first to summarize the evidence-based literature for algae oil uses in nutrition and medicine.

SOURCE OIL is the first new finished premium bulk supply of algae DHA. After consulting with the United States Department of Agriculture (USDA), the company has declared SOURCE OIL is National Organic Program (NOP) compliant since the oil and algae strain are Generally Regarded as Safe (GRAS) and not hexane extracted. The NOP compliant statement also discloses an implied Non-GMO guarantee, indicated Doughman.

Product specifications state the oil is cultured from a deep sea strain of heterotrophic Schizochytrium algae. The company seeks bulk sales for current supply capacity at 23,000 to 46,000 Kg per month.

“The oil is cultured in enclosed tanks using filtered air, filtered sea water and oxygen fermentation," explained Doughman.

Recent Class 001 and 005 trademark filings define SOURCE OIL algal extracts for use in the manufacture of dietary and nutritional supplements, foods, functional foods, medical foods, beverages, animal feeds and veterinary supplements.

According to Dr Doughman "the Schizochytrium strain in particular is positioned to be the first worldwide algae oil food source for alleviating mankind’s suffering demand for omega-3 DHA in the food supply. Plus, because peak fish oil is a reality, there is an immediate need for other sources of omega-3 oil to begin adding volumes into the capped fish oil supply. Solid data suggests the world’s omega-3 demand could outpace supply by year 2020.”